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Conventional Gab1 knockout mice display embryonic lethality with impaired development of heart, placenta, skin, and skeletal muscle. 6,7 Thus, we and others created conditional Gab1 knockout mice using the Cre-loxP technology. 8- 11 We have generated endothelium-specific Gab1 knockout (Gab1ECKO) mice and have recently reported that Gab1 is essential for postnatal angiogenesis via HGF/c-Met signaling. 5 Gab1 contributes to postnatal angiogenesis partly through activation of ERK5 and subsequent upregulation of Krüppellike factor (KLF) 2, a member of KLF. 5 KLF are a subclass of zinc finger family of transcription factors that have been implicated in the regulation of cellular differentiation and tissue development. 12 KLF2 is a key regulator of endothelial and monocyte/macrophage proinflammatory action. 12, 13 In endothelial cells (EC), KLF2 expression is induced by laminar shear stress, statin, and angiogenic growth factors, such as angiopoietin-1 and HGF. 5,12,14-18 KLF2 positively regulates both fluid shear stress-induced and statin-induced upregulation of endothelial nitric oxide synthase (eNOS) and thrombomodulin (TM) in EC, whereas inhibiting cytokine-mediated upregulation of vascular cell adhesion molecule-1 (VCAM-1). 12, 19, 20 Recently, it has been reported that KLF4, another KLF family member, shares the redundant role in vascular homeostasis and anti-inflammation with KLF2 in EC. 12,21, 22 However, the upstream regulators for gene expression of KLF2 and KLF4 in the endothelium have been illdefined. 12, 23 Atherosclerosis is a disease of the vasculature that is characterized by chronic inflammation of the arterial wall. 24 Angiotensin II (AngII), which is the main effecter of the renninangiotensin system, not only plays a role in cardiovascular homeostasis but also affects vascular endothelial function, macrophage activation, and the contraction, migration, and proliferation of vascular smooth muscle cells. 25 Chronic infusion of AngII for 28 days into apolipoprotein E (ApoE) knockout mice accelerates not only atherosclerosis but also formation of aortic aneurysms. [25] [26] [27] In the present study, we report that endothelial Gab1 deletion accelerates AngII-dependent vascular inflammation and atherosclerosis in ApoE knockout mice in association with endothelial downregulation of KLF2 and KLF4.
Methods

Antibodies and Reagents
Rat monoclonal antibody against CD31 was purchased from BD Biosciences Pharmingen; antibody against VCAM-1 from Santa Cruz Biotechnology; antibody against CD68 from Serotech; AngII, bovine serum albumin (BSA), and Oil Red O from Sigma; tumor necrosis factor (TNF)-α from PEPROTECH; Medium M-199 and TRIzol from Invitrogen. Other standard chemicals were from Wako Chemicals.
Animals
Gab1 flox mice were generated in 129/Sv-C57BL/6J mixed background as described previously. 10 Gab1ECKO mice were generated by crossing Gab1 flox/flox mice with Tie2-Cre transgenic mice on CD-1 background. 5,28 Gab1 flox/flox ; Tie2-Cre (Gab1ECKO) mice were interbred with ApoE -/mice on C57BL/6 background (The Jackson Laboratory) to generate Gab1 flox/flox ; ApoE -/-; Tie2-Cre (Gab1ECKO/ApoEKO) and Gab1 flox/flox ; ApoE -/-(ApoEKO) mice. All studies were performed with strictly age-matched, sex-matched littermate controls. All the animals used for the experiments were 6-month-old male mice maintained on a 129/Sv-C57BL/6J-CD-1 mixed background. AngII (500 ng · kg -1 · min -1 ) or saline was administered subcutaneously by Alzet osmotic minipump (model 2004; Alzet, Cupertino, CA, USA) for up to 4 weeks. 26 We housed all animals in a virus-free facility on a 12-h light/12-h dark cycle and fed them a standard mouse food. All experiments were carried out under the guidelines of Osaka University Committee for animal and recombinant DNA experiments and were approved by the Osaka University Institutional Review Board.
Genotyping
All mice were genotyped by polymerase chain reaction (PCR) using the primer sequences described as follows. 10 The Gab1 flox allele can be distinguished from the wild type Gab1 allele by PCR on genomic DNA extracted from tails, using the primer pair 5'-GCGCCTTCTTTGCATCACCTCATCT-3' and 5'-GGTAAAGCAGGTCTAGGTGGCTGACAGTCT-3'. Cre-transgene allele was detected by PCR using the primers 5'-ACATGTTCAGGGATCGCCAG-3' and 5'-TAACCAG-TGAAACAGCATTGC-3'. ApoE allele was determined by PCR using the following primers: 5'-GCCTAGCCGAGGG-AGAGCCG-3' and 5'-TGTGACTTGGGAGCTCTGCAGC-3' for wild type allele detection; 5'-GCCTAGCCGAGGGAGA-GCCG-3' and 5'-GCCGCCCCGACTGCATCT -3' for deleted allele detection.
Real-Time Reverse Transcription (RT)-PCR
Total RNA of the EC purified by magnetic cell sorting (MACS) system were extracted using TRIzol reagent (Invitrogen). Quantitative real-time RT-PCR was carried out using Quanti-Fast SYBRGreen RT-PCR kit (Qiagen) as described before. 5, 29 For each reaction, 80 ng of total RNA was transcribed for 10 min at 50°C followed by a denaturing step at 95°C for 5 min and 40 cycles of 10 s at 95°C and 30 s at 60°C. Fluorescence data were collected and analyzed using ABI PRISM 7900HT. The primers used for amplification of RNA from the purified mEC were as follows: Gab1: 5'-AAACGATCATGCCAAG-AAGC-3', 5'-TAGAAAATCCGGTCGATGGT-3'; KLF2: 5'-CTGATGACCTCGCAACAGAA-3', 5'-GTGTTCGTCA-CACACGAAGC-3'; KLF4: 5'-GAATCATTCACCAGGCA-AATTG-3', 5'-TCTGTACTGCGGGTGGAACA-3'; GAPDH: 5'-TCTCCACACCTATGGTGCAA-3', 5'-CAAGAAACA-GGGGAGCTGAG-3'. Total RNA of the aortas was extracted by TRIzol reagent and subjected to quantitative RT-PCR as described above. The primers used for amplification of RNA from the aortas were as follows: TNF-α: 5'-TGCCTATGTCT-CAGCCTCTTC-3', 5'-GGTCTGGGCCATAGAACTGA-3'; interleukin (IL)-1β: 5'-GACCTTCCAGGATGAGGACA-3', 5'-TGTTCATCTCGGAGCCTGTA-3'; IL-6: 5'-TGTGCAA-TGGCAATTCTGAT-3', 5'-GGTACTCCAGAAGACCAGA-GGA-3'.
Measurements of Blood Pressure and Metabolic Parameters
Systolic blood pressures were obtained from the conscious mice non-invasively using a computerized tail-cuff system (BP-98A-L; Softron, Japan) as described previously. 30 Mice were fasted for 12-15 h before blood was collected at the time of killing. Serum was separated by centrifugation and stored at -80°C. Serum concentrations of cholesterol, triglyceride, and glucose were determined by a commercially available enzymatic assay kits according to the manufacturer's instruction Role of Endothelial Gab1 in Atherosclerosis (Wako Chemicals, Japan).
Analysis of Atherosclerotic Lesions
At the end of AngII administration via an osmotic pump, mice were euthanized and the atherosclerotic lesions of the aortas were assessed by Oil Red O staining as described previously. 31 Briefly, after perfusion with saline, the heart, kidneys, and aorta were harvested and fixed with 4% paraformaldehyde-PBS at 4°C overnight. After careful removal of excess adventitial tissue, the aorta was immersed in 60% 2-propanol for 1 min, stained with Oil Red O at 4°C for 24-36 h, and washed in 60% 2-propanol. The aortas were opened longitudinally and pinned flat on a plain surface board. The images of the Oil Red O stained aortas were captured with a standard Canon camera and analyzed with Image J software. Results were expressed as the percentage of the positive Oil Red O color to the total aorta area.
Classification of Aneurysms and Measurement of Aortic Diameter
After perfusion with saline and 4% paraformaldehyde (PFA), the aortic tissues were harvested and immersion-fixed with 4% PFA at 4°C overnight and the periadventitial tissues were removed from the aortic wall. 32 The maximal external diameter of the suprarenal aorta was measured with a caliper. 32 Aneurysm severity was rated from Type I to Type IV according to the method of Daugherty et al: Type I, dilated lumen without thrombus; Type II, remodeled aneurysm tissue with little thrombus; Type III, a pronounced bulbous form of Type II without thrombus; Type IV, multiple, often overlapping aneurysms containing thrombus. 33
Histological Analysis
The aortic tissues were harvested and fixed with 4% PFA overnight on the indicated days after treatment with AngII or saline, cryoprotected with 20% sucrose, and frozen in OCT compound (Sakura, Japan). Cryosections (10 μm) obtained from the maximal lesion of the aneurysm were stained with either hematoxylin eosin (HE) or Elastica van Gieson (EVG) from Muto Pure Chemicals according to the manufacturer's instructions. Photographs were captured by BZ-9000 (KEYENCE, Japan).
Immunohistochemical Analysis
The aortic tissues were harvested and fixed with 4% PFA overnight on the indicated days after treatment with AngII or saline, cryoprotected with 20% sucrose, and frozen in OCT compound (Sakura). Immunostaining with the indicated antibodies were performed using the samples obtained from thoracic aortas. Cryosections (10 μm) were immunostained with the indicated antibodies using either Vectastain ABC kit (Vector) or Envision+ kit (DAKO) as described previously. 5 Photographs of immunohistochemical analyses were captured by BZ-9000 (KEYENCE).
Isolation of EC From Aortas
Aortas of 6-month-old mice were excised and subjected to Figure 1 . Grb2-associated binder 1 (Gab1) was successfully deleted in the endothelial cells (EC) from aortas of endothelium-specific Gab1 knockout (Gab1ECKO)/apolipoprotein E knockout (ApoEKO) mice. CD31-positive EC were purified from the aortas of Gab1ECKO/ApoEKO and control mice using magnetic cell sorting (MACS) system. Total RNA were extracted from these cells and subjected to quantitative realtime reverse transcription polymerase chain reaction (RT-PCR) analysis. purification of EC using a MACS system almost in the similar manner described previously. 5 Excised aortas were minced and digested with dispase II (Sankojunyaku, Japan). After centrifugation at 1,500×g for 3 min at 15°C, the cell pellets were digested with collagenase type I (Wako Chemicals). After centrifugation at 1,500×g for 3 min at 15°C, the cell pellets were suspended with PBS containing 4% fetal bovine serum. Cell suspensions were filtered. The cell debris on the filter was again digested with collagenase type II (Worthington) and filtered. The filtered cells were then incubated with rat anti-mouse CD31 antibody (BD Biosciences PharMingen), and the EC were isolated by MACS according to the manufacturer's instructions, using goat anti-rat IgG microbeads (Miltenyi Biotec). 5
Isolation of EC From Murine Lower Limb Muscles
Lower limb muscles of 8-to 10-week-old mice were excised and subjected to purification of EC using a MACS system as described previously. 5 Excised limb muscles were minced and digested with dispase II (Sankojunyaku). After centrifugation at 1,500×g for 3 min at 15°C, the cell pellets were digested with collagenase type I (Wako Chemicals). After centrifugation at 1,500×g for 3 min at 15°C, the cell pellets were suspended with PBS containing 4% fetal bovine serum. Cell suspensions were filtered. The cell debris on the filter was again digested with collagenase type II (Worthington) and filtered. The filtered cells were then incubated with rat anti-mouse CD31 anditbody (BD Biosciences PharMingen), and the EC were isolated by MACS according to the manufacturer's instructions, using goat anti-rat IgG microbeads (Miltenyi Biotec). 5
Cell Culture, Adenovirus Infection, and Stimulation With Either AngII or TNF-α
Adenovirus vector expressing human KLF2 was constructed as described previously. 5 Human umbilical vein EC (HUVEC) were purchased from Lonza and were grown in endothelial growth medium-2 (EGM-2) BulletKit (Lonza). HUVEC were used within the first 8 passages as described previously. 5 HUVEC were infected with adenovirus vectors at multiplicity of infection of 20 for 12 h. HUVEC were serum-starved by incubation with Medium M-199 containing 1% BSA. At 36 h after infection, serum-starved HUVEC were stimulated with either AngII (1 μmol/L) for 8 h or TNF-α (10 ng/ml) for 4 h and total RNA were collected using TRIzol reagent.
Statistics
All data were expressed as mean ± SEM. Differences among multiple groups were compared by 1-way ANOVA followed by a post hoc comparison tested with Scheffe's method. Student's t-test was used to analyze differences between the 2 groups. A value of P<0.05 was considered as statistically significant.
Results
Generation of Endothelium-Specific Gab1 Knockout Mice on ApoE-Null Background
To elucidate the role of endothelial Gab1 in atherosclerosis, we intercrossed Gab1ECKO (Gab1 flox/flox ; Tie2-Cre) mice with ApoE -/mice to generate Gab1 flox/flox ; ApoE -/-; Tie2-Cre (Gab1ECKO/ApoEKO) and Gab1 flox/flox ; ApoE -/-(ApoEKO; control) mice. To confirm Gab1 deletion in aortic EC, CD31positive EC were purified from the aortas of control and Gab1ECKO/ApoEKO mice using MACS system. The expression level of Gab1 mRNA in CD31-positive EC from Gab1ECKO/ApoEKO mice was significantly reduced by 77%±17% compared with that from ApoEKO mice (Figure 1) . This data indicates that Gab1 was successfully ablated in the 
Endothelial Gab1 Deletion Does Not Change Physiological and Metabolic Parameters After AngII Treatment
To determine the effect of endothelial Gab1 deletion on atherosclerosis formation, we treated ApoEKO and Gab1ECKO/ ApoEKO mice with AngII (500 ng · kg -1 · min -1 ) or saline via an osmotic infusion mini-pump for 4 weeks. AngII treatment significantly increased blood pressure and decreased body weight, whereas blood pressure and body weight either before or after AngII administration did not differ between ApoEKO and Gab1ECKO/ApoEKO mice (Table) . In addition, there was no significant difference in the profiles of lipids and glucose between ApoEKO and Gab1ECKO/ApoEKO mice after AngII treatment for 4 weeks (Table) . 
Endothelial Gab1 Deletion Accelerates AngII-Dependent Atherosclerosis Formation in ApoEKO Mice
To investigate the effect of endothelial Gab1 deletion on AngIIinduced atherosclerosis, the aortas were harvested and subjected to Oil Red O staining after treatment with AngII or saline. In the group treated with saline, there is no significant difference in atherosclerotic lesion area between ApoEKO and Gab1ECKO/ApoEKO mice (Figures 2A and B) . Whereas both Gab1ECKO/ApoEKO and ApoEKO mice showed significant increase in atherosclerotic lesion area in response to AngII treatment, Gab1ECKO/ApoEKO mice exhibited a significant increase (42%) in atherosclerotic lesion area when compared with ApoEKO littermate controls (Figures 2A and B) .
Endothelial Gab1 Deletion Accelerates AngII-Dependent Aortic Aneurysm Formation in ApoEKO Mice
AngII induces aneurysm formation in ApoE knockout mice. 26, 27 We thus examined the effect of endothelial Gab1 deletion on the abdominal aneurysm formation after AngII treatment. Compared with littermate controls, Gab1ECKO/ApoEKO mice exhibited a dramatic increase in the incidence of aneurysm formation (Figure S1) . According to the classification system of Daugherty et al, 33 we analyzed the severity of the abdominal aneurysms induced by AngII in Gab1ECKO/ApoEKO mice. The aneurysms observed in Gab1ECKO/ApoEKO were severer than those observed in ApoEKO littermate control mice (Figure 3A) . In addition, the maximal external diameters of the abdominal aneurysms were significantly increased in the aortic aneurysm of Gab1ECKO/ApoEKO mice compared with those of ApoEKO mice (Figure 3B) . HE staining revealed that GabECKO/ApoEKO mice exhibited enhanced athelosclerotic plaques compared with littermate control mice (Figure 4A) . EVG staining also revealed that aneurysm formation in Gab1ECKO/ApoEKO mice was typically associated with a disruption of the media and breaks of the elastic lamina ( Figure 4B) . Collectively, these findings indicate that endothelial Gab1 deletion accelerates AngII-dependent aneurysm formation in ApoEKO mice.
Endothelial Gab1 Deletion Leads to Enhanced Production of Proinflammatory Cytokines in ApoEKO Mice After Treatment With AngII
To reveal the molecular mechanisms of enhanced atherosclerosis and aneurysm in Gab1ECKO/ApoEKO mice, we examined the expression level of proinflammatory cytokines in the aortic tissues after AngII treatment. Using quantitative RT-PCR, we measured the expression levels of inflammatory cytokine mRNA in the aortas of ApoEKO and Gab1ECKO/ApoEKO mice after AngII infusion for 7 days. TNF-α mRNA was significantly upregulated in the aortas of Gab1ECKO/ApoEKO mice compared with those of ApoEKO mice (Figure 5A) . In addition, IL-6 and IL-1β mRNA were significantly increased in the aortas of Gab1ECKO/ApoEKO mice compared with those of ApoEKO mice (Figures 5B and C) . These findings suggest that endothelial Gab1 deletion might enhance AngIIinduced vascular inflammation via increased production of proinflammatory cytokines.
Endothelial Gab1 Deletion Results in Reduced Expression of KLF2 and KLF4 in the Aortic Endothelium
We tried to understand the reason why the inflammation was increased in the vasculature of endothelium-specific Gab1 knockout mice on ApoE-null background. It has been reported that KLF2 and KLF4 share crucial roles in endothelial homeostasis and anti-inflammation. 12,15,21, 22 We reported that Gab1 is engaged in HGF-induced upregulation of KLF2 via ERK5 in the EC. 5 We found that the expression levels of both KLF2 and KLF4 mRNA in the EC were significantly downregulated in Gab1ECKO/ApoEKO mice compared with those in littermate ApoEKO mice (Figures 6A and B) , suggesting that Gab1 is required for basal gene expression of KLF2 and KLF4 in the aortic endothelium. Consistent with this finding, we also found that the expression levels of both KLF2 and KLF4 mRNA in the CD31-positive EC purified from the limb muscles were significantly downregulated in Gab1ECKO (Gab1 flox/flox ; Tie2-Cre(+)) mice compared with those in control (Gab1 flox/flox ) mice (Figure S2A and B) .
Endothelial Gab1 Deletion Enhances VCAM-1 Expression and Macrophage Infiltration in Association With Reduced
Expression of KLF2 and KLF4 in the Aortic Endothelium KLF2 and KLF4 have been reported to potently inhibit the induction of VCAM-1 in response to various proinflammatory cytokines. 12, 20 We examined the VCAM-1 expression and macrophage infiltration by immunohistochemistry using anti-VCAM-1 and anti-CD68 antibodies, respectively. Both were enhanced in the walls of thoracic aortas from Gab1ECKO/ ApoEKO mice compared with those from control littermate mice (Figures 7A and B) . To investigate the causal relationship between expression level of KLF2 and vascular inflammation such as VCAM-1 expression, we examined the effect of adenovirus-mediated overexpression of KLF2 on VCAM-1 expression in the HUVEC. Overexpression of KLF2 could significantly inhibit both AngII-induced and TNF-α-induced upregulation of VCAM-1 mRNA in the HUVEC (Figures S3A  and B ), suggesting that KLF2 might be critically involved in prevention of AngII-induced vascular inflammation and atherosclerosis downstream of Gab1. Taken together, these findings suggest that endothelial Gab1 protects the vasculature against AngII-induced vascular inflammation and atherosclerosis in association with upregulation of both KLF2 and KLF4 genes in the endothelium.
Discussion
The present study is the first to reveal the in vivo role of endothelial Gab1 in vascular homeostasis and anti-atherosclerosis. We found that endothelial Gab1 deletion accelerated AngIIdependent atherosclerosis and aneurysm formation on ApoEnull background in association with downregulation of both KLF2 and KLF4 in the aortic EC. In addition, we also found that endothelial Gab1 deletion led to enhanced expression of VCAM-1 and macrophage infiltration in the aortic walls. Endothelium-specific deletion of Gab1 results in enhanced AngII-dependent atherosclerosis in ApoEKO mice (Figures 2A  and B) . We found that VCAM-1 expression on the aortic wall was enhanced in Gab1ECKO/ApoEKO mice compared with control littermate mice (Figure 7A) . VCAM-1 expression has been reported to precede atherosclerotic lesion formation. 34, 35 We observed enhanced infiltration of macrophage in the aortic walls in Gab1ECKO/ApoEKO mice (Figure 7B) . The enhanced expression of VCAM-1 and macrophage infiltration in the aortic walls might contribute to atherosclerosis in Gab1ECKO/ApoEKO mice. In addition, the production of proinflammatory cytokines in the aortas was augmented in Gab1ECKO/ApoEKO mice compared with control mice after AngII infusion (Figure 5) . It was reported that the proinflammatory cytokines such as IL-6, IL-1β, and TNF-α, induce the expression of VCAM-1 in EC and recruitment of mononuclear lymphocytes to EC. 36,37 Taken together, the enhanced production of proinflammatory cytokines might be involved in the AngII-dependent upregulation of VCAM-1, macrophage infiltration and subsequent atherosclerotic lesion formation in Gab1ECKO/ApoEKO mice.
The atherosclerotic phenotypes in the mice without AngII infusion were almost comparable between ApoEKO and Gab1ECKO/ApoEKO mice (Figures 2A and B) , whereas the basal expression levels of both KLF2 and KLF4 mRNA in the EC were significantly downregulated in Gab1ECKO/ ApoEKO mice compared with those in littermate ApoEKO mice (Figures 6A and B) . Further studies will be required to understand this discrepancy. In terms of upregulation of KLF2 and KLF4 gene expression, flow shear stress has a central role in the EC. 38 It was previously reported that Gab1 is tyrosinephosphorylated and positively regulates activation of eNOS and AKT by flow shear stress in the cultured EC. 39 In addition, we reported that Gab1 has a critical role for ERK5 activation and subsequent upregulation of KLF2 in the EC. 5 Taken together, fluid shear stress or growth factor such as HGF might be responsible for Gab1-dependent anti-atherosclerotic effect in the EC of aortas under stressed condition after AngII administration. 5,15, 39 KLF4 has been reported to upregulate eNOS and downregulate VCAM-1 in EC almost similarly to KLF2. 21 Therefore, KLF2 and KLF4 have been thought to have significant degree of transcriptional redundancy in EC. 12,21, 22 Although KLF2 heterozygous deficient (KLF2 +/-) mice on the ApoE-null background showed augmented atherosclerotic lesion formation by 30% compared to control littermates, the increase in atherosclerosis in the KLF2 +/mice could not be ascribed to the alterations in aortic expression of the target genes of KLF2 such as eNOS, TM, or VCAM-1. 23,40 KLF4 expression was increased by 40% in the KLF2 +/mice, 40 suggesting that the increase in KLF4 might compensate for KLF2 deficiency at least in EC. In our experiment, VCAM-1 expression was enhanced in Gab1ECKO/ ApoEKO mice compared with control littermates after AngII treatment (Figure 7A) . Together, the reduced expression of both KLF2 and KLF4 in the aortic EC of Gab1ECKO/ApoEKO mice might be associated with AngII-induced VCAM-1 expression, infiltration of macrophages in the aortic walls, and subsequent atherosclerotic lesion formation.
Collectively, these findings suggest that endothelial Gab1 protects vasculature against AngII-dependent vascular inflammation and atherosclerosis in ApoEKO mice in association with gene regulation of KLF2 and KLF4. Although further investigation is required to fully clarify the protective roles of endothelial Gab1 in the prevention of vascular inflammation and atherosclerosis, these findings indicate that Gab1 might be a novel therapeutic target for atherosclerotic vascular diseases.
Supplementary Files
Supplementary File 1 Figure S1 . All of the macroscopic photographs of the aortas after treatment with AngII for 28 days are shown. 
